2025-04-162025-04-16https://203.71.86.71/handle/123456789/152宗旨與特色 癌症藥物的研發一直是製藥產業中最為熱門也最為重要的領域，本學程成立的目的即在提昇癌症醫學及藥物研發研究人才之知識與技能，以投入醫療機構、研究機構與生物醫學相關技術產業，為未來生物醫學研究奠定基礎。本學程之成立也配合本校發展之「邁向頂尖大學」之內涵，邁向研究型大學，建立與國際一流研究單位合作，整合本校附屬機構以及校本部之研究人力及資源，加強延攬國際學者、院士與校內研究菁英，共組重點研究團隊，針對可成為國內領先的研究主題全力發展，推動跨領域整合型研究，朝向具國際競爭力之頂尖大學邁進。 107學年度增設癌症生物學與藥物研發研究所碩士班，可結合癌症生物學與藥物研發博士學位學程建構碩博一貫之完整教學體系，使學生能從基礎紮根，培養癌症生物學與藥物研發研究基本的專業知識與學習態度及相關領域的高等專業研究人才，培養對此專業有興趣及具研究潛力之碩士級研究生，在碩士班研究生學習過程中加強訓練學生原創及獨立思考的能力以及解決問題的技巧，並且引進業界教師教授生技製藥產業之發展、專利佈局及技術授權等產業課程，針對生技製藥流程與產業實地參觀及說明。並藉由提供教學與研究資源共享，招收外籍生，增加國際競爭優勢。以期對癌症的預防與治療能有更大的突破與發展。The College of Medical Science and Technology (CoMST) currently consists of one undergraduate department, two graduate institutes, two master's degree program, and five doctoral degree programs. It encompasses five major areas of specialization: Medical Science and Biotechnology, Biomedical Informatics, Cancer Biology and Drug Discovery, Neuroscience, and Translational Medicine. The CoMST was established in 2010, building upon the foundation of the School's Department of Medical Laboratory Science and Biotechnology and the Institute of Biomedical Informatics in medical applications. Starting in 2010, it collaborated with two major academic research institutions in Taiwan, the National Health Research Institutes (NHRI) and the Academia Sinica, to offer three doctoral degree programs: "Cancer Molecular Biology and Drug Discovery," "Medicine Neuroscience," and "Translational Medicine." Additionally, in 2015, 2017, 2020, and 2022, the college established the "Ph.D. Program in Medical Biotechnology," "Graduate Institute of Cancer Biology and Drug Discovery (Master)," "International Ph.D. Program for Translational Science," and "International Master Program in Medicine Neuroscience," respectively. In February 2023, the college will integrate its five major areas of specialization and degree programs into the Shuang-Ho campus, establishing close connections with Shuang-Ho Hospital and the international Biodesign program to construct an international Shuang-Ho Park jointly, cultivating biomedical talents with a global perspective and creating a benchmark institution with international influence and competitiveness. The School of Medical Laboratory Science and Biotechnology, established in 1965, has cultivated thousands of outstanding alumni with great performance in industry, government, academia and research fields. The school provides diverse and solid experimental medicine-related courses and practical training. It focuses on cultivating clinical laboratory talents, supplemented by biotechnology industry R&D personnel and medical researchers. In 2015, the newly established doctoral program in medical biotechnology brought life science research into a new era.Academic Institute